Can adrenergic blockers be leukemogenic?
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects; D002273:Carcinogens; D007938:Leukemia / Q000139:chemically induced*; D010643:Phenoxybenzamine / Q000009:adverse effects; D013565:Sympatholytics / Q000009:adverse effects*
D000317:Adrenergic alpha-Antagonists; D002273:Carcinogens; D013565:Sympatholytics; D010643:Phenoxybenzamine